Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price targe...
BTIG analyst Ryan Zimmerman reiterates PROCEPT BioRobotics (NASDAQ:PRCT) from Neutral to Neutral.
Oppenheimer analyst Suraj Kalia upgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Perform to Outperform and announces $60 pric...
Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price targe...
Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price ta...
PROCEPT BioRobotics (NASDAQ:PRCT) raises FY2025 sales outlook from $323.000 million to $325.500 million vs $324.423 million est...
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $...
